- Home
- TEVA vs GPN Comparison
TEVA vs GPN Comparison
Compare TEVA & GPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- GPN
- Stock Information
- Founded
- TEVA 1901
- GPN 1967
- Country
- TEVA Israel
- GPN United States
- Employees
- TEVA N/A
- GPN N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- GPN Business Services
- Sector
- TEVA Health Care
- GPN Consumer Discretionary
- Exchange
- TEVA Nasdaq
- GPN Nasdaq
- Market Cap
- TEVA 21.2B
- GPN 20.6B
- IPO Year
- TEVA N/A
- GPN 2001
- Fundamental
- Price
- TEVA $23.97
- GPN $76.03
- Analyst Decision
- TEVA Strong Buy
- GPN Buy
- Analyst Count
- TEVA 7
- GPN 22
- Target Price
- TEVA $25.86
- GPN $103.15
- AVG Volume (30 Days)
- TEVA 12.1M
- GPN 2.3M
- Earning Date
- TEVA 11-05-2025
- GPN 11-04-2025
- Dividend Yield
- TEVA N/A
- GPN 1.32%
- EPS Growth
- TEVA N/A
- GPN 34.30
- EPS
- TEVA 0.62
- GPN 7.12
- Revenue
- TEVA $16,776,000,000.00
- GPN $10,076,185,000.00
- Revenue This Year
- TEVA $4.11
- GPN N/A
- Revenue Next Year
- TEVA $0.40
- GPN $5.66
- P/E Ratio
- TEVA $38.84
- GPN $11.43
- Revenue Growth
- TEVA 0.02
- GPN 22.33
- 52 Week Low
- TEVA $12.47
- GPN $65.93
- 52 Week High
- TEVA $25.00
- GPN $120.00
- Technical
- Relative Strength Index (RSI)
- TEVA 76.02
- GPN 33.76
- Support Level
- TEVA $20.11
- GPN $74.71
- Resistance Level
- TEVA $25.00
- GPN $80.99
- Average True Range (ATR)
- TEVA 0.70
- GPN 2.40
- MACD
- TEVA 0.50
- GPN -0.86
- Stochastic Oscillator
- TEVA 83.00
- GPN 9.62
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About GPN Global Payments Inc.
Global Payments is a leading provider of payment processing and software solutions and focuses on serving small and midsize merchants. The company operates in 30 countries and generates about one fourth of its revenue from outside North America, primarily in Europe and Asia. In 2019, Global Payments merged with Total System Services in an all-stock deal that gave Total System Services shareholders 48% of the combined company's shares. The merger added issuer processing operations.